Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02762565 · ClinicalTrials.gov registry record · NA
Clinical Utility of a Low-Cost Hand-Held Breast Scanner
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 89
- Enrollment target
NCT02762565 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 89 participants.
The verdict
NCT02762565, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 89 participants
- Enrollment target
Study Summary
Early detection of breast cancer improves the survival rate and makes treatment less costly. This study would measure the accuracy a low-cost hand-held commercially viable device, iBE, for the detection of clinically relevant findings in the breast using the results of current mammography as a comparison. This research will have no impact on clinical decision making.
Interventions
- DEVICE PEFS system (Product Name: Intelligent Breast Exam™ or iBE™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2015-02 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02762565
The ClinicalTrials.gov registry entry for NCT02762565 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PEFS system (Product Name: Intelligent Breast Exam™ or iBE™ is the first listed.
NCT02762565 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02762565 about?
NCT02762565 is a clinical study titled "Clinical Utility of a Low-Cost Hand-Held Breast Scanner". Early detection of breast cancer improves the survival rate and makes treatment less costly. This study would measure the accuracy a low-cost hand-held commercially viable device, iBE, for the detection of clinically relevant findings in the breast using the results of current mammography as a compa...
What is the current status of trial NCT02762565?
This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 2015-02. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02762565?
The interventions under investigation include: PEFS system (Product Name: Intelligent Breast Exam™ or iBE™ (DEVICE).
Who is sponsoring clinical trial NCT02762565?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.